West Pharmaceutical Services Price to Free Cash Flow Ratio 2010-2022 | WST

Historical price to free cash flow ratio values for West Pharmaceutical Services (WST) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
West Pharmaceutical Services Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-07-06 315.55 63.01
2022-03-31 410.51 $5.01 81.97
2021-12-31 468.56 $4.33 108.14
2021-09-30 423.94 $4.44 95.46
2021-06-30 358.43 $3.74 95.93
2021-03-31 281.11 $4.05 69.41
2020-12-31 282.47 $3.93 71.83
2020-09-30 273.93 $3.65 75.10
2020-06-30 226.23 $3.72 60.78
2020-03-31 151.47 $3.28 46.25
2019-12-31 149.41 $3.19 46.78
2019-09-30 140.79 $2.86 49.25
2019-06-30 124.09 $2.66 46.63
2019-03-31 109.12 $2.46 44.30
2018-12-31 96.93 $2.44 39.74
2018-09-30 121.93 $2.55 47.89
2018-06-30 97.91 $2.28 42.86
2018-03-31 86.93 $2.20 39.56
2017-12-31 97.01 $1.75 55.50
2017-09-30 94.50 $1.38 68.25
2017-06-30 92.66 $1.10 84.16
2017-03-31 79.88 $0.92 87.06
2016-12-31 82.90 $0.66 126.38
2016-09-30 72.68 $0.65 112.24
2016-06-30 73.91 $0.91 80.92
2016-03-31 67.41 $1.05 64.21
2015-12-31 58.43 $1.09 53.37
2015-09-30 52.40 $1.04 50.53
2015-06-30 56.14 $0.99 56.46
2015-03-31 58.08 $0.85 68.23
2014-12-31 51.25 $0.98 52.55
2014-09-30 42.98 $1.14 37.78
2014-06-30 40.40 $0.99 40.95
2014-03-31 42.10 $1.25 33.60
2013-12-31 46.79 $0.96 48.70
2013-09-30 39.16 $1.05 37.47
2013-06-30 33.35 $1.03 32.25
2013-03-31 30.73 $0.42 72.61
2012-12-31 25.82 $0.78 33.04
2012-09-30 24.94 $0.39 63.91
2012-06-30 23.64 $0.28 85.50
2012-03-31 19.82 $0.36 54.95
2011-12-31 17.61 $0.48 36.91
2011-09-30 17.13 $0.72 23.91
2011-06-30 20.13 $0.93 21.73
2011-03-31 20.52 $0.87 23.69
2010-12-31 18.80 $0.92 20.54
2010-09-30 15.58 $0.90 17.41
2010-06-30 16.50 $0.63 26.10
2010-03-31 18.90 $0.75 25.27
2009-12-31 17.59 $0.45 38.92
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.672B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.676B 20.41
McKesson (MCK) United States $46.288B 13.61
AmerisourceBergen (ABC) United States $29.474B 13.60
Laboratory Of America Holdings (LH) United States $22.247B 9.29
Cooper (COO) United States $15.585B 23.99
Cardinal Health (CAH) United States $14.234B 10.93
CONMED (CNMD) United States $2.863B 29.57
Invacare (IVC) United States $0.048B 0.00